본문 바로가기
KERD
논문KCI 등재

네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 蒼朮 및 厚朴의 잠재적 치료기전 탐색

Analysis of Potential Active Ingredients and Treatment Mechanism of Atractylodes Lancea(Thunb.) D.C and Magnolia Officinalis Rehder et Wilson for Dermatitis Accompanied by Pruritus Using Network Pharmacology

김규석|김병현|남혜정|김윤범|서광일|홍예은
대한한방안이비인후피부과학회 (The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society)|2023.11|한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology)|제36권 제4호|pp. 30-50

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

PruritusNetwork pharmacologyDermatitisAtractylodes lancea(Thunb.) D.CMagnolia officinalis rehder et wilson
주제분류한의학

초록

Objectives : To investigate the active compounds and therapeutic mechanisms of Atractylodes Lancea(Thunb.) D.C. and Magnolia Officinalis Rehder et Wilson in the treatment of dermatitis accompanied by pruritus, as well as their potential to complement or replace standard drugs. Methods : We conducted the network pharmacological analysis. We selected effective ingredients among the active compounds of research target herbs. Then we explore pathway/terms of the common target proteins among research target herbs, fexofenadine and disease. Results : We selected 9 active compounds are selected from Atractylodes lancea and identified 231 target proteins. Among them, 74 proteins are associated with inflammatory skin diseases that cause pruritus. These proteins are involved in various pathways including, ‘Nitric-oxide synthase regulator activity’, ‘Hydroperoxy icosatetraenoate dehydratase activity, Aromatase activity’, ‘RNA-directed DNA polymerase activity’, ‘Arachidonic acid metabolism’, ‘Peptide hormone processing’, ‘Chemokine binding’ and ‘Sterol biosynthetic process’. Additionally, coregenes are involved in ‘IL-17 signaling pathway’. Similarly, we selected 2 active compounds from Magnolia officinalis and identified 133 target proteins. Among them, 33 proteins are related to inflammatory skin diseases that cause pruritus. These proteins are primarily involved in ‘Vascular associated smooth muscle cell proliferation’ and ‘Arachidonic acid metabolism’. There is no significant difference between the pathways in which coregenes are involved. Conclusions : It is expected that Atractylodes Lancea will be able to show direct or indirect anti-pruritus and anti-inflammatory effects on skin inflammation accompanied pruritus through suppressing inflammation and protecting skin barrier. Meanwhile, it is expected that Magnolia Officinalis will only be able to show indirect anti-inflammation effects. Therefore, Atractylodes Lancea and fexofenadine are believed to complement each other, whereas Magnolia Officialinalis is expected to provide supplementary support on skin disease.

Abstract

Objectives : To investigate the active compounds and therapeutic mechanisms of Atractylodes Lancea(Thunb.) D.C. and Magnolia Officinalis Rehder et Wilson in the treatment of dermatitis accompanied by pruritus, as well as their potential to complement or replace standard drugs. Methods : We conducted the network pharmacological analysis. We selected effective ingredients among the active compounds of research target herbs. Then we explore pathway/terms of the common target proteins among research target herbs, fexofenadine and disease. Results : We selected 9 active compounds are selected from Atractylodes lancea and identified 231 target proteins. Among them, 74 proteins are associated with inflammatory skin diseases that cause pruritus. These proteins are involved in various pathways including, ‘Nitric-oxide synthase regulator activity’, ‘Hydroperoxy icosatetraenoate dehydratase activity, Aromatase activity’, ‘RNA-directed DNA polymerase activity’, ‘Arachidonic acid metabolism’, ‘Peptide hormone processing’, ‘Chemokine binding’ and ‘Sterol biosynthetic process’. Additionally, coregenes are involved in ‘IL-17 signaling pathway’. Similarly, we selected 2 active compounds from Magnolia officinalis and identified 133 target proteins. Among them, 33 proteins are related to inflammatory skin diseases that cause pruritus. These proteins are primarily involved in ‘Vascular associated smooth muscle cell proliferation’ and ‘Arachidonic acid metabolism’. There is no significant difference between the pathways in which coregenes are involved. Conclusions : It is expected that Atractylodes Lancea will be able to show direct or indirect anti-pruritus and anti-inflammatory effects on skin inflammation accompanied pruritus through suppressing inflammation and protecting skin barrier. Meanwhile, it is expected that Magnolia Officinalis will only be able to show indirect anti-inflammation effects. Therefore, Atractylodes Lancea and fexofenadine are believed to complement each other, whereas Magnolia Officialinalis is expected to provide supplementary support on skin disease.

참고문헌 (40)

  1. Jiashuo WU, "Integration strategy of network pharmacology in Traditional Chinese Medicine : a narrative review", J Tradit Chin Med, 42(3), pp.479~486 (2022)
  2. 정민재, "가려움증의 병태생리 및 최신치료", 대한의사협회지, 61(11), pp.670~677 (2018), 대한의사협회[DOI]
  3. Ständer S, "S2k guideline : Diagnosis and treatment of chronic pruritus", J Dtsch Dermatol Ges, 20(10), pp.1387~1402 (2022)
  4. Sidbury R, "Guidelines of care for the management of atopic dermatitis : section 3. Management and treatment with phototherapy and systemic agents", J Am Acad Dermatol, 71(2), pp.327~349 (2014)
  5. Han NR, "Effect of Pyeongwee-San(KMP6)on 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC", Nga mice, 2012, pp.90(3, 4), 147~153
  6. 이진혁, "평위산가미방으로 치료한 만성 특발성 두드러기 환자의 추적조사", 한방안이비인후피부과학회지, 29(1), pp.168~173 (2016), 대한한방안이비인후피부과학회[DOI]
  7. Weisshaar E, "European S2k Guideline on Chronic Pruritus", Acta Derm Venereol, 99(5), pp.469~506 (2019)
  8. 김규남, "새는 장 증후군", Korean Journal of Family Practice, 10(5), pp.316~323 (2020), 대한가정의학회[DOI]
  9. Chi YS, "Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation : in vivo regulation of inflammation-associated gene expression", Biochem Pharmacol, 66(7), pp.1271~1278 (2003)
  10. Dickson RA, "Antibacterial and antioxidant cassane diterpenoids from Caesalpinia benthamiana", Phytochemistry, 68(10), pp.1436~1441 (2007)
  11. Nakamura T, "Eucalyptus oil reduces allergic reactions and suppresses mast cell degranulation by downregulating IgE-FcεRI signalling", Sci Rep, 10(1), pp.20940~ (2020)
  12. Zhao T, "Neohesperidin suppresses IgEmediated anaphylactic reactions and mast cell activation via Lyn-PLC-Ca(2+)pathway", Phytother Res, 33(8), pp.2034~2043 (2019)
  13. Alter BJ, "Genetic targeting of ERK1suggests a predominant role for ERK2 in murine pain models", J Neurosci, 30(34), pp.11537~11547 (2010)
  14. 안윤혜, "만성 가려움의 병태생리와 감별 진단 및 치료", Allergy Asthma & Respiratory Disease, 9(4), pp.189~202 (2021), 대한 소아알레르기 호흡기학회[DOI]
  15. Lennartsson J, "Stem cell factor receptor", c-Kit : from basic science to clinical implications, 2012, pp.92(4), 1619~1649
  16. O'Banion MK, "Cyclooxygenase-2 : molecular biology, pharmacology, and neurobiology", Crit Rev Neurobiol, 13(1), pp.45~82 (1999)
  17. Niu J, "Estrogen Receptor Alpha Gene(ESR1)Facilitates Th2-immune Response and Enhances Th2Cytokines in Experimental Atopic Dermatitis Mice", Iran J Immunol, 20(2), pp.167~176 (2023)
  18. Lichtenberger BM, "Epidermal EGFR controls cutaneous host defense and prevents inflammation", Sci Transl Med, 5(199), pp.199ra111~ (2013)
  19. Li P, "Interaction of Hsp90AA1 with phospholipids stabilizes membranes under stress conditions", Biochim Biophys Acta Biomembr, 1861(2), pp.457~465 (2019)
  20. Gęgotek A, "The proteomic profile of keratinocytes and lymphocytes in psoriatic patients", PROTEOMICS–Clinical Applications, 13(4), pp.1800119~ (2019)
  21. Zhou Z, "Exploration of the Potential Mechanism of the Common Differentially Expressed Genes in Psoriasis and Atopic Dermatitis", BioMed Research International, 2022, pp.1177299~ (2022)
  22. Simon D, "Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions", Exp Dermatol, 15(6), pp.441~446 (2006)
  23. Shinde R, "Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans", Nature immunology, 19(6), pp.571~582 (2018)
  24. Ostadhadi S, "The role of PPAR-gamma receptor in pruritus", Eur J Pharmacol, 762, pp.322~325 (2015)
  25. Lorenzo AD, "Akt1 is critical for acute inflammation and histamine-mediated vascular leakage", Proc Natl Acad Sci USA, 106(34), pp.14552~14557 (2009)
  26. Choi JE, "Skin neurogenic inflammation", Semin Immunopathol, 40(3), pp.249~259 (2018)
  27. Andoh T, "Nitric oxide enhances substance P-induced itch-associated responses in mice", Br J Pharmacol, 138(1), pp.202~208 (2003)
  28. Tekin NS, "Nitric oxide levels in patients with psoriasis treated with methotrexate", Mediators Inflamm, 2006(3), pp.16043~ (2006)
  29. Zheng Y, "Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation : a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope", J Biol Chem, 286(27), pp.24046~24056 (2011)
  30. Jin J, "Estrogen alleviates acute and chronic itch in mice", Exp Ther Med, 25(6), pp.255~ (2023)
  31. Molès JP, "Cytosolic RNA : DNA Duplexes Generated by Endogenous Reverse Transcriptase Activity as Autonomous Inducers of Skin Inflammation in Psoriasis", PLoS One, 12(1), pp.e0169879~ (2017)
  32. Yosipovitch G, "Itch : From mechanism to(novel)therapeutic approaches", J Allergy Clin Immunol, 142(5), pp.1375~1390 (2018)
  33. Nillni EA, "Posttranslational Processing of Progrowth Hormone-Releasing Hormone1", Endocrinology, 140(12), pp.5817~5827 (1999)
  34. Yosipovitch G, "Skin Barrier Damage and Itch : Review of Mechanisms, Topical Management and Future Directions", Acta Derm Venereol, 99(13), pp.1201~1209 (2019)
  35. Zhang Z, "Reinforcement of barrier function-skin repair formulations to deliver physiological lipids into skin", Int J Cosmet Sci, 40(5), pp.494~501 (2018)
  36. Guan J, "Skin-associated adipocytes in skin barrier immunity : A mini-review", Front Immunol, 14, pp.1116548~ (2023)
  37. Liu T, "The IL-23", IL-17 Pathway in Inflammatory Skin Diseases : From Bench to Bedside, 2020, pp.11, 594735~
  38. Banerjee S, "JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases : Current and Future Prospects", Drugs, 77(5), pp.521~546 (2017)
  39. 서광일, "네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 枳實의 잠재적 치료기전 탐색", 한방안이비인후피부과학회지, 35(4), pp.75~94 (2022), 대한한방안이비인후피부과학회
  40. Li C, "Research on the effect and underlying molecular mechanism of Cangzhu in the treatment of gouty arthritis", Eur J Pharmacol, 927, pp.175044~ (2022)

관련 논문AI추천

네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 枳實의 잠재적 치료기전 탐색김규석, 김병현, 김윤범, 김준동, 남혜정, 서광일대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2022 · 제35권 제4호네트워크 약리학을 이용한 소양증을 동반한 피부 염증에 대한 陳皮의 잠재적 치료기전 탐색김규석, 김병현, 김윤범, 남혜정, 이은경, 이희재, 홍예은대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제1호네트워크 약리학을 활용한 심상성 건선에 대한 澤瀉의 잠재적 작용 기전 탐색 연구김규석, 김윤범, 남혜정, 박수진, 이은경, 이희재, 홍예은대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2025 · 제38권 제3호아토피 피부염에 대한 인진호 추출물의 네트워크 약리학 분석 및 효능김대용, 김미혜대한미용학회 · 대한미용학회지2024 · 제20권 제3호네트워크 약리학적 방법론을 활용한 한의학 효능 연구 고찰권영규, 백종민, 서한길한의병리학회 · 동의생리병리학회지2016 · 제30권 제6호최근 20년간 한약을 중심으로 한 아토피 질환 치료에 대한 계량서지학적 분석김종한, 박수연, 박혜진, 손소은, 전현준, 정민영, 정소미, 최정화대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2023 · 제36권 제2호

이 간행물의 다른 논문 (15건)

한방안이비인후피부과로 입원한 환자들의 특성 분석 -2018년 3월부터 2023년 2월까지 대전대학교 대전한방병원에서-최윤영, 변정아, 백종찬, 김서희, 정현아pp. 1-18안과 질환으로 한방안이비인후피부과에 의뢰된 한방병원 입원 환자에 대한 고찰서형식, 허은나, 권강, 정미래pp. 19-29당뇨병성 망막병증에 대한 補陽還五湯의 효과: 체계적 문헌 고찰 및 메타분석김혜나, 오정화, 윤화정pp. 51-69안면마비의 테이핑 요법에 대한 임상 연구 동향이규영pp. 70-87구강작열감증후군의 한의학적 치료에 대한 최근 국내외 임상 연구 동향최지민, 홍석훈pp. 88-112
원문 보기